Healthcare Venture Partners
VC Fund
Charleston, United States
Healthcare Venture Partners is a VC fund in Charleston focused on Software and Biopharma. Healthcare & Life Sciences Investment Firm
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Healthcare Venture Partners invests in
Stages Healthcare Venture Partners invests in
Countries Healthcare Venture Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Michael Mashaal
|
|||
|
Jeffrey C. Lightcap
|
|||
Investment Focus
Industry
- Software 1 (50%)
- Biopharma 1 (50%)
- Health Care 1 (50%)
- Life Science 1 (50%)
- Biotechnology 1 (50%)
Stage
- Series B 1 (50%)
- Series C 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Michael Mashaal
Senior Managing Director
|
Senior Managing Director | Total investments: 1 | Find email | |
|
Jeffrey C. Lightcap
Senior Managing Director
|
Senior Managing Director | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Myome
|
Myome helps identify genes that cause disease and act based on leading science. The data is secure, portable, and reusable throughout life. | $23M / Series B / Jun 21, 2022 | |
Paige
|
Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The Company builds computational pathology products designed so patients and their care teams can make effective, more informed treatment decisions. With this new class of diagnostic devices positioned to drive the future of pathology,Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s lightweight platform was purpose-built with pathologists to offer an intuitive user experience, minimize IT burden and costs while ensuring patient safety and data privacy. Paige’s products deliver insights to pathologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA breakthrough designation for computational pathology products. | $125M / Series C / Jan 14, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Healthcare Venture Partners invest in?
Healthcare Venture Partners invests primarily in Software, Biopharma and Health Care startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Healthcare Venture Partners?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Healthcare Venture Partners?
The team at Healthcare Venture Partners includes Michael Mashaal (Senior Managing Director) and Jeffrey C. Lightcap (Senior Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
